TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 3,739 clinical trials

Featured trial
T Test Invetigator

AutoRun122494

AutomationRun122494

100 years and younger Male Phase N/A
Featured trial
B Bulk OSP

AutoRun122495

AutomationRun122495

100 years and younger Male Phase N/A
Featured trial
C Cookie Site User

Cookie Testing

Cookie Testing

17-77 years Female Phase N/A
Featured trial
I Investigator 1

New STudy 3

1 years and older All Phase N/A
Featured trial

Investigation of the Effects of Balance Discs With Different Surfaces Used in Balance Education in Children With Cerebral Palsy on Proprioceptive Sense and Balance.

This is a non-invasive prospective study investigating the effects of balance discs with different surfaces used in balance education in children with cerebral palsy on proprioceptive sense and balance.

12 years and younger All Phase N/A
Featured trial

Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer

The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tolerability of immunotherapy-based combination therapy.

18 years and older All Phase 2
Featured trial
A Alaa Ali, Ph.D.

Non - Incised Papilla Versus Single Flap Technique In The Reconstruction Of Intrabony Defect

The present study will aim to assess the effectiveness of the non-Incised Papilla surgical approach NIPSA used for the surgical debridement of deep intraosseous defects compared to the single-flap approach SFA. Primary outcome: interproximal clinical attachment level gain Secondary outcomes: residual probing pocket depth (PPD), pocket depth (PD) reduction, recession …

18 years and older All Phase N/A
Featured trial
J John smIth

A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.

To study the safety and toxicity of intranasal peptide T (D-Ala-1-peptide-T-amide) in humans, and to find out how quickly and how much of a given dose enters the bloodstream and how quickly it leaves the bloodstream. To obtain information on the ability of intranasal peptide T to prevent, halt, and/or …

18 years and older All Phase 1
Featured trial
F Francesca Di Martino, Pharmacy

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive

Aim of this study is to evaluate Daratumumab effect on MRD-positive patients with Multiple Myeloma (MM) who achieved >VGPR after any therapy (ASCT, VMP, Rev-Dex). Daratumumab 16 mg/kg administered at weekly intervals for 8 weeks, then every 2 weeks for an additional 16 weeks, will be given to 50 MM …

18-85 years All Phase 2
Featured trial
C Charles MESGUICH, Dr

Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma

Multiple myeloma (MM) survival has been improved during the last decade owing to new treatments. Hence, it has become a matter of importance to precisely define the depth of MM response to therapy. 18F-FDG PET/CT (FDG-PET) has proved to be superior to X-rays for the initial staging of MM. It …

18 years and older All Phase 3

Simplify language using AI